SI2552485T1 - Imunoglobulini polne dolžine igg izotipa, sposobni prepoznave heteropodtipskega nevtralizacijskega epitopa na hemagglutininskem izvornem področju in njih uporaba kot zdravilo proti gripi - Google Patents
Imunoglobulini polne dolžine igg izotipa, sposobni prepoznave heteropodtipskega nevtralizacijskega epitopa na hemagglutininskem izvornem področju in njih uporaba kot zdravilo proti gripiInfo
- Publication number
- SI2552485T1 SI2552485T1 SI201131130A SI201131130A SI2552485T1 SI 2552485 T1 SI2552485 T1 SI 2552485T1 SI 201131130 A SI201131130 A SI 201131130A SI 201131130 A SI201131130 A SI 201131130A SI 2552485 T1 SI2552485 T1 SI 2552485T1
- Authority
- SI
- Slovenia
- Prior art keywords
- recognizing
- full
- stem region
- igg isotype
- neutralizing epitope
- Prior art date
Links
- 101710154606 Hemagglutinin Proteins 0.000 title 1
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 title 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 title 1
- 101710176177 Protein A56 Proteins 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000000185 hemagglutinin Substances 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
- 229940072221 immunoglobulins Drugs 0.000 title 1
- 206010022000 influenza Diseases 0.000 title 1
- 230000003472 neutralizing effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000237A ITTO20100237A1 (it) | 2010-03-26 | 2010-03-26 | Immunoglobuline intere della classe delle igg per l'uso come medicamento antinfluenzale |
IT000067A ITTO20110067A1 (it) | 2011-01-26 | 2011-01-26 | Immunoglobuline intere di isotipo igg atte a riconoscere un epitopo di neutralizzazione eterosubtipica sulla regione stelo (stem region) dell'emoagglutinina e loro uso come medicamento antinfluenzale |
PCT/IB2011/051284 WO2011117848A1 (en) | 2010-03-26 | 2011-03-25 | Full-length immunoglobulins of the igg isotvpe capable of recognizing a heterosubtvpe neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament |
EP11721645.7A EP2552485B1 (en) | 2010-03-26 | 2011-03-25 | Full-length immunoglobulins of the igg isotype capable of recognizing a heterosubtype neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2552485T1 true SI2552485T1 (sl) | 2017-05-31 |
Family
ID=44168279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201131130A SI2552485T1 (sl) | 2010-03-26 | 2011-03-25 | Imunoglobulini polne dolžine igg izotipa, sposobni prepoznave heteropodtipskega nevtralizacijskega epitopa na hemagglutininskem izvornem področju in njih uporaba kot zdravilo proti gripi |
Country Status (7)
Country | Link |
---|---|
US (1) | US20130022608A1 (sl) |
EP (1) | EP2552485B1 (sl) |
CN (1) | CN102958539B (sl) |
EA (1) | EA029198B1 (sl) |
HR (1) | HRP20170490T1 (sl) |
SI (1) | SI2552485T1 (sl) |
WO (1) | WO2011117848A1 (sl) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITTO20080204A1 (it) | 2008-03-17 | 2009-09-18 | Pomona Biotechnologies Llc | Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a |
ITTO20080398A1 (it) | 2008-05-27 | 2009-11-28 | Pomona Biotechnologies Llc | Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1 |
US20120128684A1 (en) * | 2008-08-25 | 2012-05-24 | Burnham Institute For Medical Research | Conserved Hemagglutinin Epitope, Antibodies to the Epitope and Methods of Use |
ITTO20080964A1 (it) | 2008-12-22 | 2010-06-23 | Natimab Therapeutics S R L | Anticorpo monoclonale anti-hcv come medicamento per il trattamento terapeutico e la prevenzione di infezioni da hcv |
IT1395961B1 (it) * | 2009-06-01 | 2012-11-02 | Pomona Biotechnologies Llc | Anticorpi monoclonali come medicamento per il trattamento terapeutico e/o profilattico delle infezioni da virus influenzale a (h1n1) di origine suina (s-oiv) |
ES2687706T3 (es) * | 2010-06-17 | 2018-10-26 | Trellis Bioscience, Llc | Anticuerpos útiles en la inmunización pasiva contra la gripe |
JP6325451B2 (ja) | 2011-12-02 | 2018-05-16 | アイム・セラピューティクス・べー・フェー | A型インフルエンザに特異的な抗体 |
WO2013086052A2 (en) | 2011-12-05 | 2013-06-13 | Trellis Bioscience, Llc | Antibodies useful in passive influenza immunization |
US9969794B2 (en) | 2012-05-10 | 2018-05-15 | Visterra, Inc. | HA binding agents |
TWI657095B (zh) | 2012-11-13 | 2019-04-21 | 美商建南德克公司 | 抗血球凝集素抗體及使用方法 |
AU2014236508A1 (en) | 2013-03-14 | 2015-09-17 | Contrafect Corporation | Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy |
KR20140118682A (ko) * | 2013-03-29 | 2014-10-08 | (주)셀트리온 | 2 이상의 인플루엔자 a 바이러스 중화 결합 분자를 포함하는 조성물 |
RU2536956C1 (ru) * | 2013-08-05 | 2014-12-27 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт пульмонологии Федерального медико-биологического агентства" | Противовирусное однодоменное мини-антитело, нуклеотидная последовательность, экспрессирующий рекомбинантный вирусный вектор, фармацевтическая композиция и способ профилактики или терапии гриппа типа а |
US10639370B2 (en) | 2014-02-04 | 2020-05-05 | Contrafect Corporation | Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof |
WO2015120097A2 (en) | 2014-02-04 | 2015-08-13 | Contrafect Corporation | Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof |
DK3105250T3 (da) * | 2014-02-10 | 2020-09-28 | Igm Biosciences Inc | Multispecifikke iga-bindingsmolekyler |
TWI702229B (zh) | 2014-12-19 | 2020-08-21 | 美商再生元醫藥公司 | 流行性感冒病毒血球凝集素之人類抗體 |
AU2016246065B2 (en) * | 2015-04-08 | 2021-06-03 | Dana-Farber Cancer Institute, Inc. | Humanized influenza monoclonal antibodies and methods of use thereof |
WO2017083627A1 (en) | 2015-11-13 | 2017-05-18 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
AU2020248404A1 (en) | 2019-03-25 | 2021-09-30 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
CN117487003A (zh) * | 2022-08-02 | 2024-02-02 | 东莞市朋志生物科技有限公司 | 抗乙型流感病毒抗体或其功能性片段、检测乙型流感病毒的试剂和试剂盒 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITTO20080204A1 (it) * | 2008-03-17 | 2009-09-18 | Pomona Biotechnologies Llc | Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a |
ITTO20080398A1 (it) * | 2008-05-27 | 2009-11-28 | Pomona Biotechnologies Llc | Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1 |
IT1395961B1 (it) * | 2009-06-01 | 2012-11-02 | Pomona Biotechnologies Llc | Anticorpi monoclonali come medicamento per il trattamento terapeutico e/o profilattico delle infezioni da virus influenzale a (h1n1) di origine suina (s-oiv) |
-
2011
- 2011-03-25 EP EP11721645.7A patent/EP2552485B1/en active Active
- 2011-03-25 US US13/637,030 patent/US20130022608A1/en not_active Abandoned
- 2011-03-25 WO PCT/IB2011/051284 patent/WO2011117848A1/en active Application Filing
- 2011-03-25 SI SI201131130A patent/SI2552485T1/sl unknown
- 2011-03-25 EA EA201290955A patent/EA029198B1/ru not_active IP Right Cessation
- 2011-03-25 CN CN201180015849.0A patent/CN102958539B/zh active Active
-
2017
- 2017-03-24 HR HRP20170490TT patent/HRP20170490T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
EP2552485B1 (en) | 2017-03-08 |
HRP20170490T1 (hr) | 2017-06-02 |
EP2552485A1 (en) | 2013-02-06 |
WO2011117848A1 (en) | 2011-09-29 |
CN102958539B (zh) | 2015-07-01 |
EA029198B1 (ru) | 2018-02-28 |
CN102958539A (zh) | 2013-03-06 |
US20130022608A1 (en) | 2013-01-24 |
EA201290955A1 (ru) | 2013-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI2552485T1 (sl) | Imunoglobulini polne dolžine igg izotipa, sposobni prepoznave heteropodtipskega nevtralizacijskega epitopa na hemagglutininskem izvornem področju in njih uporaba kot zdravilo proti gripi | |
IL283173A (en) | Variants of human IGG1 FC region and uses thereof | |
EP2739312A4 (en) | HUMAN ANTIBODY OF GENERAL NEUTRALIZATION THAT RECOGNIZES THE BINDING POUCH OF THE INFLUENZA HEMAGGLUTININ RECEPTOR | |
CO2018004321A2 (es) | Anticuerpo que neutraliza el virus respiratorio sincitial humano | |
IL265774B (en) | Diagnosis, prevention and treatment of joint diseases | |
EP2705057B8 (en) | Therapeutic canine immunoglobulins and methods of using the same | |
HK1204576A1 (en) | Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti- jagged antibodies and methods of use thereof jagged1/jagged2 jagged | |
BR112014018005A2 (pt) | uso de complexo não covalente imobilizado e variante de região fc de isotipo igg1 humano | |
EP2814841A4 (en) | HUMAN MONOCLONAL ANTIBODIES FOR WIDE PROTECTION AGAINST INFLUENZA B VIRUS AND METHOD OF USE THEREOF | |
IL268822A (en) | Medical uses of anti-beta 7 monoclonal antibodies or fragments thereof | |
HK1201282A1 (en) | Antibodies against human csf-1r and uses thereof csf-1r | |
HK1200740A1 (en) | Combination therapy of antibodies against human csf-1r and uses thereof csf-1r | |
LT2734545T (lt) | Antikūnai, neutralizuojantys influenza a virusą, ir jų panaudojimo būdai | |
EP2708260B8 (en) | A device for the care of respiratory diseases and the improvement of pulmonary function | |
EP3088517A4 (en) | Human anti-il-33 neutralizing monoclonal antibody | |
IL221760A (en) | Human monoclonal antibodies derived from human b cells with neutralizing anti-influenza viruses | |
SG11201404147YA (en) | Computationally optimized broadly reactive antigens for human and avian h5n1 influenza | |
EP2797629A4 (en) | AGLYCOSYLATED HUMAN ANTIBODY AND FUSION PROTEIN AND USES THEREOF | |
PL2758004T3 (pl) | Tymczasowe modułowe urządzenie dystansowe dla stawów w ciele człowieka | |
WO2012026878A8 (en) | Monoclonal antibody specific to major neutralizing epitope of influenza h5 hemagglutinin | |
LT2814843T (lt) | ŽMOGAUS MONOKLONINIAI ANTIKŪNAI, NEUTRALIZUOJANTYS IL-1ß | |
IL275884A (en) | Human antibodies to influenza hemagglutinin | |
WO2012108650A3 (ko) | 뇌졸중의 치료제 또는 진단제로서 프로테이나아제-3에 대한 단클론 항체의 용도 | |
ZA201304490B (en) | Neutralizing human anti-v3 monoclonal antibodies and use thereof for the production of vaccine against hiv | |
GB2504889B (en) | Therapeutic canine immunoglobulins and methods of using the same |